Psyence Biomedical Ltd. Common Shares (PBM) is a publicly traded Healthcare sector company. As of November 19, 2026, PBM trades at $2.62 with a market cap of $9.57M and a P/E ratio of 0.00. PBM moved +4.38% today. Year to date, PBM is -48.82%; over the trailing twelve months it is -85.85%. Its 52-week range spans $1.92 to $74.94. Rallies surfaces PBM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for PBM, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $2.62 |
| Market Cap | $9.57M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $74.94 |
| 52-Week Low | $1.92 |
| Volume | 210 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
PBM analyst coverage data. Average price target: $0.00.